Infinity Pharma teams up with AbbVie for cancer drug

Now watching

Next video starts in : 7 Play

Infinity Pharma teams up with AbbVie for cancer drug

Infinity Pharma teams up with AbbVie for cancer drug
Replay video
Up next

Cramer's stock to watch: Clorox

Unlock your personal NFL Now stream by signing in to NFL.com

Infinity Pharma teams up with AbbVie for cancer drug

by CNBC Videos 1:41 mins

Infinity Pharma will receive $275 million upfront from AbbVie, as part of a new venture to develop blood cancer treatments. Infinity CEO Adelene Q. Perkins, explains the significance of the deal, with CNBC's Meg Tirrell.

View Comments (0)